Key Dates

Related Announcements

• August 24, 2023 -Community Partnerships to Advance Science for Society (ComPASS): Health Equity Research Hubs (UC2 Clinical Trial Optional). See NOFO RFA-RM-23-012

Issued by

Office of Strategic Coordination (Common Fund)

Purpose

The purpose of this Notice is to:

1) inform the community of a change to the Application Instructions with a correction to the page limits for the Research Strategy section of the PHS 398 Research Plan; and

2) to clarify that the Milestones and Timeline section of the application should be included as an attachment to the PHS 398 Research Plan and not included as part of the Research Strategy section of the PHS 398 Research Plan for RFA-RM-23-012 Community Partnerships to Advance Science for Society (ComPASS): Health Equity Research Hubs (UC2 Clinical Trial Optional).

Section IV. Application and Submission Information

2. Content and Form of Application Submission

Page Limitations

Currently reads:

All page limitations described in the SF424 Application Guide and the Table of Page Limits must be followed.

Revised to read (changes in bolded italics):

All page limitations described in the SF424 Application Guide and the Table of Page Limits must be followed, with the following exceptions or additional requirements:

For this specific NOFO, the Research Strategy section is limited to 24 pages and must include the Overview section, as well as the unit-specific Sections 1-4 and Sub-sections A-E under Research Strategy.

Section IV. Application and Submission Information

2. Content and Form of Application Submission

SF424(R&R) Other Project Information

Currently reads:

Milestones and Timeline: This attachment must include the Hub timeline and major milestones. This attachment supplements, but does not replace, the Milestones section of the Research Strategy. The filename must be labeled as “Milestones and Timeline.pdf”.

Revised to read (changes in bolded italics):

Milestones and Timeline: This attachment must include the Hub timeline and major milestones. The milestones and timeline should be included as an attachment, filename labeled as "Milestones and Timeline.pdf" and submitted under the Other Attachments section of the R&R Other Project Information form.

All other aspects of this Funding Opportunity Announcement remain unchanged.

Inquiries

Please direct all inquiries to:

Amanda M. Acevedo, Ph.D.
National Cancer Institute (NCI)
Telephone: 240-276-5896
Email: [email protected]